Logo
x

Search

Subscribe Now

pharma

PharmaShots’ Key Highlights of First Quarter 2025

PharmaShots’ Key Highlights of First Quarter 2025

  • April 1, 2025
Alloy Therapeutics Enters into a Multi-Year Strategic Collaboration with Pfizer to Develop New Antibody Discovery Platform

Alloy Therapeutics Enters into a Multi-Year Strategic Collaboration with Pfizer to Develop New Antibody Discovery Platform

  • February 12, 2025
Relmada Therapeutics Acquires Sepranolone from Asarina Pharma for ~$3.12M

Relmada Therapeutics Acquires Sepranolone from Asarina Pharma for ~$3.12M

  • February 7, 2025
How Pharma and Social Work Can Collaborate on Chronic Disease Management

How Pharma and Social Work Can Collaborate on Chronic Disease Management

  • February 6, 2025
Biogen and Neomorph Collaborate to Discover and Develop Molecular Glue Degraders (MGD)

Biogen and Neomorph Collaborate to Discover and Develop Molecular Glue Degraders (MGD)

  • October 30, 2024
GV20 Therapeutics Collaborates with Merck to Evaluate GV20-0251 + KEYTRUDA in Patients with Advanced Solid Tumors

GV20 Therapeutics Collaborates with Merck to Evaluate GV20-0251 + KEYTRUDA in Patients with Advanced Solid Tumors

  • April 19, 2024
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2025 PharmaShots - All Rights Reserved.